共 50 条
EUS-guided core biopsies of pancreatic solid masses using a new fork-tip needle: A multicenter prospective study
被引:39
|作者:
Di Leo, Milena
[1
,2
]
Crino, Stefano Francesco
[3
]
Bernardoni, Laura
[3
]
Rahal, Daoud
[4
]
Auriemma, Francesco
[1
]
Correale, Loredana
[6
]
Donato, Giulio
[5
]
Massidda, Marco
[1
]
Anderloni, Andrea
[1
]
Manfrin, Erminia
[7
]
Armellini, Elia
[5
]
Poliani, Laura
[1
]
Fugazza, Alessandro
[1
]
Semeraro, Rossella
[1
]
Occhipinti, Pietro
[5
]
Repici, Alessandro
[1
,2
]
Carrara, Silvia
[1
]
机构:
[1] Humanitas Res Hosp, Div Gastroenterol, Digest Endoscopy Unit, Via Manzoni 56, I-20089 Milan, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] GB Rossi Univ Hosp, Pancreas Inst, Gastroenterol & Digest Endoscopy Unit, Verona, Italy
[4] Humanitas Res Hosp, Pathol Dept, Milan, Italy
[5] Osped Maggiore La Carita, Digest Endoscopy Unit, Novara, Italy
[6] Ctr Prevenz Oncol, Turin, Italy
[7] GB Rossi Univ Hosp, Dept Diagnost & Publ Hlth, Verona, Italy
关键词:
FNA;
FNB;
Pancreatic adenocarcinoma;
SharkCore needle;
Tissue acquisition;
DIAGNOSTIC-ACCURACY;
TISSUE ACQUISITION;
ASPIRATION;
LESIONS;
22-GAUGE;
FNA;
TRIAL;
D O I:
10.1016/j.dld.2019.03.025
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background and aim: Endoscopic ultrasound-guided sampling (EUS sampling) is a safe and effective technique. The study aim was to evaluate the presence of a histological core from pancreatic lesions using a new 25G fork-tip needle. Methods: Observational multicenter prospective and analytical study, including consecutive patients with solid pancreatic masses referred for EUS-guided sampling. At each needle pass, the endoscopist performed macroscopic on-site evaluation (MOSE). The primary outcome was the histological core procurement rates. Secondary outcomes were the evaluation of interobserver agreement between endoscopists and pathologists, adequacy of EUS samples for the diagnosis and post-procedure adverse events. Results: 100 patients were enrolled in 3 centers. The mean size of the lesions was 28.5 mm (SD 11.7). Final diagnoses were adenocarcinoma (68%), neuroendocrine tumor (21%), inflammatory mass/benign lesions (8.0%), and pancreatic metastasis (3.0%). The pathologists described the presence of a core in 67 samples (67.0% of patients), with poor agreement with MOSE (kappa, 0. 12; 95% CI: 0.03-0.28). The diagnostic accuracy was 93%. We observed 6% of mild adverse events. Conclusion: The new 25-gauge core needle showed good overall adequacy and a good rate of histological specimens during EUS sampling of solid pancreatic masses, with a minimum number of passes and no major complications. (C) 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1275 / 1280
页数:6
相关论文